Mr. Speaker, constituents of Don Valley North would agree that increasing Canada's bio-manufacturing capacity is an important part of our recovery plan. That is why we moved quickly to expand vaccine manufacturing capacity across the country.
Throughout the COVID-19 pandemic, our objectives have always been very clear: to provide Canadians with safe and effective vaccine and treatments and to return our economy and society back to normal.
Could the Prime Minister provide us with an update on what we have done to enable domestic vaccine production?